Deflazacort Tablets 6mg.

Pacitora Biotech presents Truflaz-6™, a high-quality formulation containing Deflazacort 6mg tablets. Deflazacort is a synthetic glucocorticoid (corticosteroid) with powerful anti-inflammatory and immunosuppressive properties. It is a oxazoline derivative of prednisolone that offers distinct advantages over conventional glucocorticoids, particularly a better metabolic and bone safety profile.

Key Benefits:

• Potent Anti-Inflammatory – Effective for a wide range of inflammatory conditions.

• Immunosuppressive Action – Controls overactive immune responses.

• Fewer Metabolic Side Effects – Less weight gain, glucose intolerance & bone loss than prednisolone.

• Improved Bone Safety – Lower risk of osteoporosis compared to other glucocorticoids.

• Once-Daily Dosing – Convenient morning dosing schedule.

FAQs:

1. What is Truflaz-6 (Deflazacort) used for?
Truflaz-6 is used for inflammatory, allergic, and autoimmune conditions including rheumatoid arthritis, lupus, nephrotic syndrome, asthma, ulcerative colitis, and multiple sclerosis relapses. It is often preferred when long-term steroid therapy is needed.

2. How is Deflazacort different from Prednisolone?
Deflazacort has fewer metabolic side effects – it causes less weight gain, less glucose intolerance (better for diabetics), and significantly less bone loss (osteoporosis). One 6mg tablet of Deflazacort is approximately equal to 5mg of Prednisolone.

3. What are the common side effects of Truflaz-6?
Short-term: facial flushing (harmless), insomnia, increased appetite (less than prednisolone). Long-term: weight gain, glucose intolerance, adrenal suppression, and bone loss (but significantly less than prednisolone). Take with food to reduce stomach irritation.

4. What happens if I stop taking Truflaz-6 suddenly?
Sudden withdrawal after long-term use (over 2-3 weeks) can cause adrenal crisis – a life-threatening condition with severe weakness, nausea, vomiting, low blood pressure, and shock. Always taper off gradually under medical supervision.